Video length 00:08:14
The ETF industry remains quite resilient despite the pandemic, with more than 150 new ETF launches in 2020. In this video, we focus on three very innovative virus-themed ETFs that made their debut recently.
We all are waiting for a breakthrough that will allow a return to normal, and there have been some very encouraging developments in the global race for coronavirus vaccines and treatments. There’s a lot of investor interest in companies that are working to develop coronavirus vaccines and therapeutics but picking a virus winner is not easy.
The ETFMG Treatments, Testing And Advancements ETF (GERM - Free Report) provides a diversified exposure to many promising biotech companies. Moderna (MRNA - Free Report) and Novavax (NVAX - Free Report) are its top holdings.
The pandemic has accelerated the remote work trend and it may continue even after this crisis.
The Direxion Work From Home ETF (WFH - Free Report) offers exposure to 40 companies that stand to benefit from an increasingly flexible work environment. Its top holdings include Twilio (TWLO - Free Report), Zoom Video (ZM - Free Report), and Okta (OKTA - Free Report).
The Pacer BioThreat Strategy ETF (VIRS - Free Report) focuses not only on firms involved in the development of vaccines and treatments, but it takes a broader approach to structural trends that are emerging as a result of this pandemic. Nvidia (NVDA - Free Report) and Amazon (AMZN - Free Report) are its top holdings.
Comments
Log in or sign up to join the conversation.